complement C3

complement C3

Beta-1-C-globulin, factor A A 180 kD serum protein; normal concentration 70–150 mg/dL, which is ↑ in chronic inflammation, bile obstruction, amyloidosis, severe protein malnutrition; ↓ in complement activation, immune complex disease, immunologic disease, bacteremia, genetic disease
References in periodicals archive ?
Apellis Pharmaceuticals will provide an update with 18-month data on its Phase 2 trial of its complement C3 inhibitor, APL-2, in patients with geographic atrophy associated with age-related macular degeneration.
Treatment with blisibimod also was associated with a reduction in anti-double-stranded DNA antibodies, as well as significant reductions in peripheral B-cell lineages, anticardiolipin antibodies, and immunoglobulins, and with significant increases in complement C3 and C4.
12) suggested that lymphopenia, prednisone treatment, and low levels of complement C3 were independent risk factors for the development of a set of diverse and severe infections (not only opportunistic infections) in SLE patients.
Complement C3 (C3) has important effects on damage of target organs and tissues in systemic lupus erythematosus (SLE).
The following blood tests were also performed: liver function tests; blood lipid levels; immunoglobulin (IG) G (IgG), IgM, IgA, antistreptolysin O, rheumatoid factor, complement C3 and complement C4 levels; testing for the presence of antinuclear antibodies (ANAs), anti-double stranded-DNA antibodies, anti-phospholipase A2 receptor antibodies, c-anti-neutrophil cytoplasmic antibodies, and p-anti-neutrophil cytoplasmic antibodies; the ratio of blood monospecific free light chain; immunoassay electrophoresis; and hepatitis B and C serology.
Serum complement C3 and C4 levels in relation to diagnosis of lupus nephritis.
The complement C3 inhibitor of US-based autoimmune disease therapeutics developer Apellis Pharmaceuticals, Inc.
Autologous IgG and complement C3 fragments are markers of phagocytes removal (24).
Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.
Complement C3 and C4 levels were determined by radial immune diffusion and confirmed by chemiluminescence method as required.
recent pyoderma or pharyngitis with positive anti-streptolysin-O titers, anti-DNAse B titers or throat swab positive for Group A streptococcus) and (c) Low serum complement C3 level.
2 Coagulation factor XI (c) Complement C1r (c) Actin (c) Complement C3 (c) Complement C4B (c0 Talin-1 (c) Apolipoprotein B-100 (c) Complement C5 (c) Ceruloplasmin (c) Alpha-1 antichymotrypsin (c) Inter alpha trypsin inhibitor (c) Kallistratin (c) Corticosteroid-binding globulin (c) Serum paraoxonase (c) Fibronectin (c) Plasmonogen like protein A (c) Complement C2 (c) Fibrinogen alpha chain (c) Extracellular matrix protein-1 (c) Collagen alpha 3 (c) Protein disulphide isomerase A3 (c) LFQ LC-MS/MS Fold change (a) T = 24 h vs Protein description T = 30 min Fibrinogen gamma chain 1.

Full browser ?